News - Hypertension Week of Jan. 26, 2003/ Vol. 2 No. 04

Company Recalls Anti-Hypertensive Tablets

Herbsland Inc. is recalling all 100-tablet bottles of Ancom Anti-Hypertensive Compound Tablets.

The tablets, which are not U.S. Food and Drug Administration (FDA) approved, contain several prescription drug ingredients, including reserpine, diazepam, promethiazine, and hydrochlorothiazide.

The sale of a product with this combination of ingredients poses possible serious health risks including sedation, depression, and potentially life-threatening abnormalities of the blood, according to the FDA.

The recall includes all lot codes of the product remaining on the market. Ancom Tablets were sold without prescriptions to consumers through distributors and retail stores located in the New York City metropolitan area, specifically Manhattan, Brooklyn and Queens. Nationwide sales are also possible since the product was sold on-line.

No illnesses have been reported to date. Consumers who have used this product and are experiencing any adverse reactions should seek advice from their physician for appropriate evaluation and treatment of their hypertension.

Consumers who purchased the tablets are urged to immediately discontinue use of the product and return it to the place of purchase for a full refund. Consumers with questions may contact the company at 1-917-480-9170.

Other sources: Herbsland